Bioprinting is a technology derived from additive manufacturing and 3D printing, producing three-dimensional structures, layer by layer, from a digital model (CAD) using different biomaterials and cell types. The spheroid- and organoid-based technologies developed by Gcell can be used as building blocks in 3D Bioprinting to achieve biological tissues on a macro scale.

Laboratory-constructed biological tissues using 3D bioprinting are excellent alternatives to medical devices and prostheses and are part of advanced therapy products in regenerative medicine.

​

Gcell works on customized 3D bioprinting projects through service provision and open innovation projects for public and private companies and science and technology institutions.

​